Streetbeat News

Revenues

TSNDF

TerrAscend Corp. has completed the acquisition of Herbiculture Inc., a medical dispensary in Maryland. This acquisition marks TerrAscend's fourth dispensary in the state, reaching the cap. The company expects Herbiculture to drive substantial sales and profit growth, especially with the recent launch of adult-use sales in Maryland. The transaction is expected to be immediately accretive to TerrAscend on an EBITDA and cashflow basis.

Portfolio Pulse from Vuk Zdinjak

July 10, 2023 | 12:19 pm

CBAT

CBAK Energy has announced a three-year partnership with Echom for a lithium-ion battery order worth RMB 180 million. The partnership is expected to boost CBAK Energy's revenues and market presence.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 12:01 pm

NSTG

NanoString Technologies, Inc. (NASDAQ:NSTG) has released a preliminary update for Q2 2023, expecting revenues to exceed $44 million, a YoY growth of approximately 37%. The company has also retained more than $30 million in the CosMx instrument order backlog, despite a competitor's attempt to scare off customers. The company's spatial biology revenue is expected to be over $23 million, and nCounter revenue is expected to be approximately $21 million. The company reiterated its full-year revenue guidance of $175 million-$185 million.

Portfolio Pulse from Nabaparna Bhattacharya

July 10, 2023 | 11:50 am

FMC

FMC Corporation's shares are trading lower after the company issued weak revenue guidance due to volume declines in three of its four operating regions.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 11:36 am

FMC

FMC Corporation has revised its FY23 revenue guidance to $5.2B-$5.4B, which is lower than the estimated $6.11B.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 11:35 am

FMC

FMC Corporation has revised its Q2 revenue forecast to $1.0B-$1.03B, significantly lower than the previous estimate of $1.45B. The company attributes this to unexpected volume declines in three out of its four operating regions towards the end of May.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 11:35 am

HELE

Helen of Troy has projected its FY24 revenue to be between $1.965 billion and $2.015 billion, which is in line with the estimated $2 billion.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 10:49 am

IMOS

ChipMOS reported Q2 2023 revenue of $174.8M, an increase of 18.2% from Q1 2023 but a decrease of 20.5% from Q2 2022. June 2023 revenue was $57.4M, down 2.5% from May 2023 and 15.3% from June 2022.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 10:04 am

NSTG

NanoString has reiterated its FY23 revenue guidance of $175M-$185M, which is above the consensus estimate of $174.78M.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 9:05 am

NSTG

NanoString (NSTG) expects Q2 sales to exceed $44M, a 37% increase YoY, surpassing the company's guidance of $40M-$42M and consensus of $41M. Spatial biology revenue is expected to be over $23M, in line with consensus, while nCounter revenue is expected to be around $21M, above the guidance range of $17M-$18M and consensus of $18M.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 9:03 am